Multi-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Open Access
- 5 June 2017
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 8 (8) , 5636-5643
Abstract
Alzheimer's disease (AD) is a multifactorial disease that is characterized by the formation of intracellular neurofibrillary tangles and extracellular amyloid-β (Aβ) plaque deposits. Increased oxidative stress, metal ion dysregulation, and the formation of toxic Aβ peptide oligomers are all considered to contribute to the etiology of AD. In this work we have developed a series of ligands that are multi-target-directed in order to address several disease properties. 2-(1-(3-Hydroxypropyl)-1H-1,2,3-triazol-4-yl)phenol (POH), 2-(1-(2-morpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PMorph), and 2-(1-(2-thiomorpholinoethyl)-1H-1,2,3-triazol-4-yl)phenol (PTMorph) have been synthesized and screened for their antioxidant capacity, Cu-binding affinity, interaction with the Aβ peptide and modulation of Aβ peptide aggregation, and the ability to limit Aβ1–42-induced neurotoxicity in human neuronal culture. The synthetic protocol and structural variance incorporated via click chemistry, highlights the influence of R-group modification on ligand-Aβ interactions and neuroprotective effects. Overall, this study demonstrates that the phenol–triazole ligand scaffold can target multiple factors associated with AD, thus warranting further therapeutic development.Keywords
Funding Information
- Michael Smith Health Research BC
- Alzheimer's Association (NIRG-15-362537)
- Fondation Brain Canada
- Alzheimer's Society of Canada
- Canadian Institutes of Health Research
- Canada Research Chairs
This publication has 72 references indexed in Scilit:
- Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s miceScience, 2016
- A review on Alzheimer's disease pathophysiology and its management: an updatePharmacological Reports, 2015
- Biological metals and metal-targeting compounds in major neurodegenerative diseasesChemical Society Reviews, 2014
- The Ongoing Search for Small Molecules to Study Metal-Associated Amyloid-β Species in Alzheimer’s DiseaseAccounts of Chemical Research, 2014
- Untangling Amyloid-β, Tau, and Metals in Alzheimer’s DiseaseACS Chemical Biology, 2013
- Bioinorganic Chemistry of Alzheimer’s DiseaseChemical Reviews, 2012
- Alzheimer's disease, a multifactorial disorder seeking multitherapiesAlzheimer's & Dementia, 2010
- Alzheimer's DiseaseNew England Journal of Medicine, 2010
- The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to TherapeuticsScience, 2002
- The molecular pathology of Alzheimer's diseaseNeuron, 1991